vTv Therapeutics Inc.
VTVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $79,698 | $23,977 | $50,913 | $62,335 |
| - Cash | $36,746 | $9,446 | $12,126 | $13,415 |
| + Debt | $169 | $529 | $716 | $932 |
| Enterprise Value | $43,121 | $15,060 | $39,503 | $49,852 |
| Revenue | $1,017 | $0 | $2,018 | $4,005 |
| % Growth | – | -100% | -49.6% | – |
| Gross Profit | $1,017 | $0 | $2,018 | $4,005 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$22,516 | -$25,863 | -$24,766 | -$17,515 |
| % Margin | -2,214% | – | -1,227.3% | -437.3% |
| Net Income | -$18,462 | -$20,250 | -$19,164 | -$12,987 |
| % Margin | -1,815.3% | – | -949.7% | -324.3% |
| EPS Diluted | -3.2 | -9.71 | -9.98 | -8.29 |
| % Growth | 67% | 2.7% | -20.4% | – |
| Operating Cash Flow | -$25,307 | -$19,081 | -$15,246 | -$19,308 |
| Capital Expenditures | $0 | $0 | -$21 | $0 |
| Free Cash Flow | -$25,307 | -$19,081 | -$15,267 | -$19,308 |